Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.88 and traded as high as $1.84. Mesoblast shares last traded at $1.84, with a volume of 5,246 shares changing hands.
Mesoblast Price Performance
The stock’s 50-day simple moving average is $1.15 and its 200 day simple moving average is $0.88.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Further Reading
- Five stocks we like better than Mesoblast
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Top 3 Investment Themes to Watch for in 2025
- Stock Market Upgrades: What Are They?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Business Services Stocks Investing
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
